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ABSTRACT 
Nitric oxide synthesis by chicken macrophages results in coordinated changes of multiple 
arginine transporters 
Michael Moulds 
Arginine transport is primarily mediated by the cationic amino acid transporters (CATs) in 
mammalian cells, but in aves the y
+
, b
0,+
 and B
0,+
 transport systems have also been observed. 
Arginine is the limiting catabolic substrate required for the production of nitric oxide (NO), a 
highly reactive compound that acts as a signaling molecule or killing compound. NO is 
synthesized by inducible nitric oxide synthase (iNOS) by macrophages for pathogen clearance. 
In mammals, CAT-2B is responsible for ARG import in the macrophage for NO synthesis, but 
the chicken CAT-2B isoform does not transport ARG. Therefore the objective of these studies 
was to identify the CAT(s) involved in mediating ARG uptake during a NO response in the 
chicken macrophage. Experiments were performed to measure: 1) ARG transporter mRNA and 
NO production from three sources of macrophages (HD11 cell line, n=6; primary 32d Cobb 500, 
n=8; Hyline W36, n=7) in response to Escherichia coli lipopolysaccharide (LPS); 2) the effect of 
CAT over-expression on NO production in response to LPS (HD11 cell line; n=8). In response to 
LPS iNOS mRNA abundance increased (P<0.05) 8.5-fold in the HD11 macrophages, 3.22-fold 
in broiler macrophages and 2.79-fold in layer macrophages. In all cells, CAT-1 was induced and 
CAT-2A increased (P<0.05) between 1.28 and 1.68-fold. CAT-2B was not detected at any time 
point or treatment condition. In the virally transformed chicken macrophage cell line (HD11) 
CAT-3 mRNA was induced, but in primary cells CAT-3 increased (P<0.05) 1.27-fold in broilers 
and 1.23-fold in layers. Transiently transfected chicken macrophages produce NO independent 
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of LPS treatment by 6h, mock transfected controls did not respond by 6h. In the presence of LPS, 
CAT-1 transfected macrophages produced 50.0% more NO than mock transfected cells (P<0.05). 
CAT-2A and CAT-3 transfected macrophages produced only 17.6% and 72.1% of the total NO 
produced by controls (P<0.05). These results indicate that CAT-1 and CAT-3 are both sufficient 
to sustain ARG import for NO production in the chicken macrophage, but that CAT-1 produces a 
maximal response. These results also show that iNOS, despite its name, is constitutively present 
and can be activated by induction of CATs to import ARG. 
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CHAPTER 1 
Introduction 
1.1. Overview of the Immune System 
 The immune system consists of innate and adaptive branches that provide non-specific, 
broadly specific and highly specific responses to pathogens and antigens. These different 
branches are coordinated through cytokine signaling and receptor-mediated immune cell 
interactions [1, 2]. The innate branch of the immune system is constitutive and the first response 
to pathogens or antigens. It acts using broadly specific or non-specific responses and recognizes 
pathogens with via broadly specific pathogen associated molecular patterns [2, 3]. This innate 
immune recognition does not alter or improve with repeat exposure [1]. In addition to 
constitutive barriers like the skin and mucous membranes, the innate immune system includes 
granulocytes (basophils, eosinophils, and neutrophils/heterophils), natural killer cells, dendritic 
cells and macrophages/monocytes [3, 4]. Granulocytes each target a broad-type response, but 
they are all phagocytic cells that contain granules of lytic enzymes and anti-microbial molecules. 
Basophils mediate allergic responses and eosinophils target parasitic infections [3-5]. 
Neutrophils are involved in bacterial infections and are one of the first cell types to arrive in 
response to cytokine release [3, 5]. Natural killer cells target a myriad of stressed cell types 
including virally infected cells, tumor cells and damaged cells [6, 7]. Dendritic cells and 
macrophages are phagocytic and antigen presenting cells that provide a link between innate and 
adaptive immune responses [8-10]. 
 The adaptive immune response is characterized by the development of antigen-specific 
effector and memory cells [11]. It provides cell-mediated and humoral immunity with cytotoxic 
2 
 
T lymphocytes, T helper (TH) cells and B cells [1, 3, 11]. Cytotoxic T lymphocytes target 
intracellular pathogens and B cells target extracellular pathogens [3, 5]. B cells produce a wide 
variety of immunoglobulins (Ig), or antibodies, in response to pathogen recognition or antigen 
stimulation [3, 10, 12]. IgM is the first Ig secreted by B cells and is secreted as a pentamer [3, 5]. 
In generating a more targeted immune response, B cells also switch Ig type in addition to 
undergoing receptor rearrangement [3, 5]. The most common isotype produced by activated 
mature B cells is IgG, but others include IgA, IgD and IgE [3, 4]. IgA is a secretory antibody 
produced in mucosal lymphoid tissue as a dimer [4]. IgE is produced in response to parasitic 
infections and triggers the degranulation of mast cells during an allergic reaction. Many sub-
types of TH cells augment the effector functions of both innate and adaptive immune cells 
through the production of cytokines [1, 2, 11]. TH1 cells produce pro-inflammatory cytokines 
including interferon- γ (IFN-γ) and aid in macrophage activation [13-16]. TH2 lymphocytes 
produce interleukin-10 (IL-10) and transforming growth factor- β (TGF-β), cytokines that 
stimulate B cells and increase antibody production [2, 3, 8]. TH17 cells are named for their 
production of IL-17, a cytokine involved in neutrophil recruitment to the site of an infection [3, 
5]. Both TH1 and TH2 cytokines are cross inhibitory, thus a TH1 type response prevents TH2 and 
TH17; TH2 inhibits TH1 and TH17 activation [3]. Additionally, Treg cells maintain the inactive 
state of TH cells through the production of TGF-β until they are down regulated [2, 3]. 
 The tissues of the immune system are classified as primary or secondary lymphoid tissues 
based on their function. Primary immune tissues are sites of lymphopoeisis and lymphocyte 
maturation. B cells are produced and develop in the bone marrow of mammals and in the bursa 
in aves; T cells develop in the thymus [3, 4, 11]. Lymphocytes leave primary lymphoid tissues as 
self-tolerant mature naïve cells [11, 17]. Secondary lymphoid tissues such as the spleen, lymph 
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nodes and gut, bronchial, mucosal and cutaneous associated lymphoid tissues are where 
lymphocytes encounter antigens [4]. These tissues are also the sites of lymphocyte proliferation, 
Ig class switching and receptor hyper-variability [3, 5].  
1.1.1 Macrophages 
 Macrophages, or activated monocytes, are phagocytic and antigen presenting cells of the 
innate immune system, but they are also involved in wound healing and tumor suppression [18-
20]. Macrophages exist in peripheral blood as monocytes and become active once they leave 
circulation, or extravasate, and enter tissue [8, 21, 22]. Primary macrophages isolated from tissue 
and primary monocytes isolated from blood exhibit similar responses when activated. Both types 
of cell isolates produce reactive nitrogen species, actively phagocytose, synthesize cytokines and 
increase major histocompatibility II expression [23, 24]. Many specialized macrophages, or 
macrophage-like cells, exist in numerous tissues including alveolar macrophages in the lungs, 
Kupffer cells in the liver, microglial cells in the nervous tissue and osteoclasts in bone [25, 26]. 
 Macrophages and macrophage-like cells recognize pathogens through the use of pattern 
recognition receptors including mannose-binding lectin, the toll-like family of receptors (TLR), 
antibody-antigen complexes and acute phase protein interactions [9, 10, 27-30]. Primary and cell 
line macrophages behave as their in vivo counterparts through phagocytosis, antigen presentation 
and cytokine production [10, 31]. The chicken macrophage cell line (HD11) is an immortalized 
cell line that was virally transformed by the avian myelocytomatosis virus (MC29) [32]. The 
MC29 virus creates tumors and immortalizes cells in part by altering the transcription factor myc 
[33]. The differences between primary macrophages and HD11s, as a model for L-arginine 
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(ARG) dependent nitric oxide (NO) production, remain similar despite 20 years of animal 
breeding and continual culture [31]. 
 The differences between primary macrophages and cell lines are complex and may or 
may not accurately represent the in vivo immune response. While the HD11 cell line is a pure 
population of macrophages and thus removes the interactions of contaminating cell types in 
vitro, an in vivo immune challenge recruits neutrophils, TH cells, natural killer cells in addition to 
circulating antibody and acute phase proteins [6, 34]. However, as a cell line the HD11 
macrophages can survive and vigorously respond to simulated immune challenges without co-
stimulation or exogenous survival factors. Even using targeted B cell and T cell antibodies and 
compliment, lymphocyte removal peripheral blood samples is typically only 95% [23]. Semi-
pure macrophage populations derived from peripheral monocytes thus may include a variety of T 
cells and B cells which could more accurately mimic the in vivo response in vitro. As such in the 
comparison of a homogenous, transformed cell population and a moderately heterogeneous, wild 
type cell population, both are incomplete but potentially useful in describing the extremely 
heterogeneous conditions in the chicken. 
 
1.1.2 Macrophage Activation 
 Macrophages and monocytes can be activated through a variety of signals and receptor 
binding ligands. Among these receptors, Toll-like receptor 4 (TLR-4) recognizes 
lipopolysaccharide (LPS) constitutively found in gram-negative cell walls [35, 36]. Activating 
macrophages with LPS requires a complex of TLR-4 with CD-14 and MD-2 [35].  LPS-binding-
protein (LBP) with bound LPS can also activate macrophages by binding CD-14 [35, 36]. TLR-2 
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in heterodimers with TLR-1 or TLR-6 can bind a variety of ligands including peptidoglycan, 
bacterial lipoproteins, lipoarabinomannan and zymosan [29]. In addition TLR-5 binds bacterial 
flagellin [29]. Intracellular pathogens are detected by TLR-3, TLR-7 and TLR-9 which respond 
to double stranded RNA, single stranded RNA and CpG DNA in turn [29, 37]. In association 
with their co-ligands these receptors can each initiate an immune response directed either at 
intracellular or extracellular pathogens. Macrophages also express a variety of Fc receptors and 
thus can target antibody-antigen complexes for phagocytosis [8, 12]. 
 Once a macrophage is activated with LPS, this signal is propagated using MyD88 and the 
serine/threonine kinase IL-1 receptor activated kinase (IRAK) to ultimately activate the 
transcription factor nuclear factor κB (NFκB) [28, 37-40]. The increase in available NFκB results 
in a pro-inflammatory immune response with increased transcription of inducible nitric oxide 
synthase (NOS2 or iNOS) and IL-1β, IL-6, IL-8, IL-12 and TNF-α production [40-43]. Similar 
macrophage activation can be achieved using TNF-α alone or in combination with LPS [10, 43, 
44]. These cytokines enhance immune function, induce acute phase protein synthesis, serve as 
chemoattractants for neutrophils, direct a TH1 type response and aid in extravasation to improve 
immune cell exfiltration [6, 13, 36]. 
 
1.1.3 Macrophage Functions 
 Once activated, macrophages actively phagocytose and destroy bacteria utilizing a 
respiratory burst mechanism [10, 15, 45]. The respiratory burst produces bactericidal compounds 
known as the reactive oxygen species (ROS) and reactive nitrogen species (RNS). The RNS and 
ROS produced include hydrogen peroxide, superoxide anion, peroxynitrite and nitric oxide (NO) 
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[46, 47].  All of these compounds are capable of causing oxidative damage to kill invading 
microorganisms [48, 49]. Even in a culture devoid of immune cells, NO is capable of killing 
Leishmania major [50]. NO contributes to anti-viral immunity by interfering with replication of 
DNA and protein synthesis [21]. In conjunction with H2O2, NO causes double stranded DNA 
cleavage, depletion of the antioxidant glutathione and increased death in E. coli [51]. The stable 
byproducts of NO, nitrate and nitrite, are also bacteriostatic [46, 48]. 
 NO has other biological uses and can be synthesized by neuronal nitric oxide synthase 
(nNOS or NOS1) or endothelial nitric oxide synthase (eNOS or NOS3) which are both 
constitutive Ca
2+
 dependent isoforms [52, 53]. These constitutive forms synthesize NO for 
neurotransmission (nNOS) or vasoregulation (eNOS) [53]. The isoform utilized by macrophages 
to synthesize NO, iNOS is Ca
2+
 insensitive and associates with the Ca
2+
 binding protein, 
Calmodulin (CaM) in Ca
2+
 free media [21, 54]. Macrophages do however undergo rapid 
oscillations in intracellular Ca
2+
 concentration upon activation and this may provide the minimal 
amount required to saturate CaM [55]. Sustained production of NO is reliant on intracellular L-
arginine (ARG), NADPH and oxygen. D-arginine cannot be utilized for NO production, but 
neither does it inhibit NO synthesis [21, 31, 56]. The reaction also requires flavin adenine 
dinucleotide (FAD), flavin mononucleotide (FMN), tetrahydrobiopterin (BH4), and heme as co-
factors [57, 58]. The active NOS enzyme regardless of isoform is a tetramer of two NOS 
monomers associating with two CaM monomers [57]. Constitutive nNOS requires 200-300 nM 
free Ca
2+
 to bind CaM and achieve half-maximal NO production [59, 60]. In mice, the CaM-
binding region is the sequence residue 501-532 and is responsible for Ca
2+
 independent 
activation of iNOS [60]. Regardless of isoform, the terminal amino group of ARG is cleaved to 
produce NO and its co-product l-citrulline (CIT) [56]. Negative feedback from NO production 
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can occur through the production of stable nitrosyl species. This weakly inhibits iNOS, but has 
been shown to inactivate as much as 90% of active nNOS [61]. 
Once pathogens have been destroyed in the phagolysosome by the respiratory burst, they 
are processed for antigen presentation to by the endocytic pathway. The endocytic pathway 
processes antigens for presentation on major histocompatibility complex type II (MHC II) [11]. 
Antigen loaded on MHC II is presented to TH cells, which are recruited to augment the innate 
immune response [8, 11]. The process of antigen presentation and recognition is crucial for 
pathogen clearance and the required for the development of immunological memory [8].  
 Macrophage cytokine production is important for immune clearance by activating a pro-
inflammatory environment and recruiting adaptive immune cells [10]. Macrophages induce TH 
cells into a TH1 type response with the production of IL-12 and IL-18, a response which results 
in the TH1 cells producing macrophage augmenting cytokines[10, 62]. The cytokines IL-1β and 
IL-6 assist in T cell activation and can induce fever [40, 63]. TNF-α further increases 
inflammation and can trigger apoptosis in damaged and/or tumor cells through its receptor [13, 
40]. With the assistance of TH1 produced cytokines, notably IFN-γ and the resulting increase in 
MHC I or human leukocyte antigen (HLA) expression, activated macrophages have improved 
tumor cell recognition and destruction capacity [20, 64].  
 Once pathogen clearance has been achieved, macrophages are involved in the subsequent 
healing of the wounded environment [18, 19]. The enzyme arginase reduces the available 
substrate for NO synthesis and retards the inflammation [56]. In the mouse macrophage, 
Salmonella has been shown to up-regulate this pathway to survive inside phagocytic 
compartments [15]. In addition to pathogen clearance, damaged or dead cells are induced to 
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undergo apoptosis or are scavenged by macrophages [20]. Furthermore, cytokine production 
recruits additional cells to the wound and improves angiogenesis [18]. The inhibition of 
macrophages to limit collateral tissue damage and down-regulate activity post-pathogen 
clearance relies on TH2 cytokines TGF-β and IL-10 [18, 27]. 
1.2 Nutrition and the Immune Response 
 Nutrition, metabolism and the immune response are interdependent and intermodulatory. 
For example, exposure to LPS induces a febrile response through the production of pro-
inflammatory cytokines and reduces nutrient intake [65, 66]. This innate response also modulates 
nutrient availability on a tissue level by  decreases amino acid uptake in skeletal muscle while 
increasing it in the liver and leukocytes [2]. The extensively studied metabolic hormone insulin 
regulates energy metabolism and promotes glucose uptake and utilization. Insulin also acts on 
immune cells such as lymphocytes which preferentially utilize glucose as an energy source [67]. 
Nutritional status, such as starvation, can result in impaired T lymphocyte function in response to 
low levels of leptin [68]. Leptin is also a regulatory hormone involved in food intake, basal 
metabolism and energy expenditure [67, 68]. 
 Nutrition can also modulate immunity and metabolism [69]. Nutrient modulation occurs 
through numerous mechanisms including increased substrate supply for immune cells (amino 
acids, Mg, Zn) or pathogens (Fe), protection from immunopathology (Vitamin E, Se, 
carotenoids), altering signal transduction in immune cells (Vitamins A, D, E), altering gut 
microbial populations (fiber) and hormonal balance [1, 2, 69, 70]. 
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 1.2.1 Arginine Utilization 
 ARG, as a nutritional substrate for the immune system, has a role in immunomodulation 
[69]. Depletion of circulating ARG has been shown in abdominal sepsis, trauma, post-surgically 
and in cancer models [71]. Conversely, supplementation with dietary ARG improves wound 
healing and improved survival versus tumors in mammals [18, 67, 71]. In addition to utilization 
by macrophages, ARG is required for T cell proliferation, expression of the T cell receptor 
complex and the development of memory T cells [71]. In the absence of ARG, CD4
+
 T cells 
exhibit decreased CD3δ chain expression, but this effect is reversible by ARG supplementation 
[72]. This decrease in CD3δ can be replicated by depleting ARG with arginase I, but not arginase 
II or iNOS [72]. Increased lymphoid organ weights have also been observed in response to 
higher dietary levels of ARG in chickens [69]. Additionally high dietary ARG improves T cell 
proliferation and increases circulating monocyte percentages in growing broiler chicks [73]. 
Mature B cell proliferation and antibody production is not adversely affected by ARG 
deprivation or early supplementation [74]. In mice, ARG deprivation during development results 
in lower B cell numbers in the spleen and lymph nodes [75]. The implications of high dietary 
ARG in chickens in production may be confounded by differences in production and 
experimental facilities [69].   
 1.2.2 Arginine Metabolism 
 ARG is an essential, or conditionally essential, cationic amino acid depending on species 
differences in ARG metabolism [56, 76, 77]. These differences correlate with ureotelic and 
uricotelic nitrogen excretion strategies. ARG is processed through two major metabolic cycles 
and is a precursor for many other products, the urea cycle and the Citrulline-NO cycle (Figure 1) 
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[56]. It is also used for protein synthesis and is a precursor of NO, CIT, urea, ornithine, 
polyamines, proline, glutamate and agmatine [56]. In aves and other uricotelic species, ARG is a 
dietarily essential amino acid because they lack the complete array of urea cycle enzymes [76]. 
The complete urea cycle consists of five enzymes: arginase, carbamoylphosphotate 
synthetase I (CPS I), ornithine transcarbamoylase (OTC), argininosuccinate synthetase (ASS) 
and argininosuccinate lysase (ASL) [56]. Chickens lack mitochondrial CPS I and have low ASL, 
ASS and OTC activity [76]. In mammalian, or ureotelic, species the complete urea cycle is 
present and allows for ARG recycling [56, 77]. In young, growing animals ARG recycling is 
insufficient to meet metabolic needs and it is dietarily essential [77]. Mature, healthy adults can 
meet their ARG requirement without supplementation [56]. While ARG synthesis occurs in the 
liver and kidney, the co-localization of urea cycle enzymes in the liver results in hepatic ARG 
being utilized for urea synthesis [56, 77]. As such, in ureotelic species most de novo synthesized 
plasma ARG is of renal origin. ARG is thus conditionally essential in ureotelic organisms based 
on growth, age and health status. 
 The Citrulline-NO cycle consists of only three enzymes, NOS, ASS and ASL. This can 
occur, albeit inefficiently, in most NO producing cell types independent of the active NOS 
isoform [77]. As such, CIT supplementation in uricotelic and ureotelic animals is unable to 
support high levels of NO synthesis in culture, but chickens can meet their ARG requirements by 
dietary supplementation [76, 78]. Mammals however, can supply their ARG requirements from 
ARG, CIT or ornithine supplementation [77]. Despite possessing the necessary enzymes, 
mammalian macrophages are unable to utilize CIT for NO synthesis [79, 80]. 
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Figure 1. Overview of the Urea and Citrulline-NO cycles. The chicken lacks a complete urea 
cycles because they lack carbamoylphosphate synthase I and have low activity of ornithine 
transcarbamoylase (*), but these enzymes are present in ureotelic mammals. Abbreviations: 
ASL, argininosuccinate lysase; ASS, argininosuccinate synthetase; L-Arg. Succ., L-
argininosuccinate; CPS I, carbamoylphosphate synthase I; Carbamoyl P., carbamoyl phosphate; 
OTC, ornithine transcarbamoylase. Adapted from Sung et al 1991 [31]. 
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1.3 Arginine Transport 
 Immune cells and tissues, like other tissues, have different nutrient demands and 
priorities during different physiological states [2]. Macrophages, for example, are a high nutrient 
priority cell type within the immune system followed by B cells and T cells in decreasing priority 
[81]. It follows that sepsis and wound healing are nutritionally demanding physiological states 
[19]. These nutrients are obtained and prioritized by groups of nutrient transporters derived from 
the solute carrier (SLC) superfamily of genes. Transporters are further divided based on 
substrate, with three families capable of encoding ARG transporters: the system y
+
 cationic 
amino acid transporters (CAT; SLC7A), systems y
+
L and b
0,+
 glycoprotein-associated amino 
acid transporters (gpaAT; SLC7A and SLC3A) and system B
0,+
 the Na
+
/Cl
-
 dependent 
transporter (ATB
0,+
; SLC6A) [19]. As a cationic amino acid (CAA), ARG shares these transport 
systems with other CAAs such as lysine and ornithine [56, 82]. 
1.3.1 System y
+
 
System y
+
 consists of the glycosylated transmembrane transporters CAT1-4 with 12-14 
transmembrane domains and cytosolic N and C-termini (Table 1) [19, 82-84]. CAT-2 is 
alternatively spliced into CAT-2A and CAT-2B in mammals and also into the truncated CAT-2C 
isoform in chickens [82, 85, 86]. CAT-4 exhibits approximately 40% homology to the other 
CATs and has been identified as a CAT in plants, but its function in mammals and aves is not 
clearly understood [86, 87]. 
The predominant transporter of the y
+
 system in mammals is CAT-1, a high affinity 
transporter with a Km range of 0.10-0.16 mM [19, 88]. It is constitutively expressed in most cell 
types with the notable exception of hepatocytes in adult mammals. Its expression can be 
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modified by cell proliferation, cytokines, hormones and nutrients [56, 88, 89]. In nutrient replete 
conditions CAT-1 expression is low, but amino acid deprivation upregulates CAT-1 mRNA [88]. 
CAT-1 is vital to post-natal growth and development, knockout mice lacking the gene are runts 
(~25% smaller) and die within 12h of birth [90]. Functional CAT-1 knockout models have been 
developed using embryonic fibroblasts and while fetal development is impaired, embryonic cells 
are still viable [90, 91]. In contrast, CAT-2 knockout mice are viable and fertile [45, 92]. CAT-
2A is a low affinity transporter with a reported Km of 2-5 mM and is found in the primarily in the 
liver and skeletal muscle [19, 45, 83]. The alternative CAT-2 splicing produces a high affinity 
isoform, CAT-2B with a Km similar to CAT-1 and CAT-3 [19, 82, 85, 86]. The expression of 
CAT-2B in mammals is required for NO production in response to LPS or cytokine stimulation 
in macrophages, but not in fibroblasts [45, 92]. In other cell types, an absence of CAT-2B can 
impair NO synthesis to differing degrees [93, 94]. CAT-2B and iNOS are co-induced  in 
mammalian macrophages and CAT-2B preferentially transports ARG utilized by iNOS [45, 89]. 
The substrate affinity difference in the CAT-2 isoforms is determined by a 41 amino acid 
sequence in the fourth intracellular region of the protein [19, 83, 86]. The chicken CAT-2B has a 
crucial amino acid substitution when compared with the mammalian transporter. At the substrate 
affinity conferring site, residue 369, a glutamine is replaced with lysine [85].  CAT-3 is also a 
high affinity transporter and is found in the brain and thymus [19, 56, 84, 86]. In CAT-1 
deficient models, such as fibroblasts, CAT-3 can functionally restore ARG transport for NO 
synthesis [91]. 
Like mammals, chickens express different CAT isoforms depending on the tissue, 
however the tissue distributions sometimes differs from their mammalian counterparts. CAT-1 is 
not as ubiquitously expressed as it is in mammals and is found in the liver, skeletal muscle and 
14 
 
bursa but not in the heart, spleen or thymus [17]. CAT-2 is expressed in the liver, skeletal 
muscle, bursa, heart, spleen and thymus [17]. Like mammals, chickens also splice CAT-2 into 
multiple transporters, but they produce three variants: CAT-2A, CAT-2B and CAT-2C [85]. 
However, unlike mammals, CAT-2B is incapable of ARG transport and CAT-2C is a non-
functional truncated protein [85]. CAT-3 is expressed in some skeletal muscle (pectoralis) but 
not in others (gastrocnemius). It is also expressed in the bursa, heart, spleen and thymus, but not 
in the liver [17]. The expression of the various chicken CATs also depends on physiological 
conditions including stage of development, health status and nutrient availability. For example, 
no isoform of CAT mRNA was detectable in the thymus or spleen until day 7 post hatch [17]. 
An immune challenge with LPS has no effect on CATs in the thymus, but increased CAT mRNA 
in the liver and bursa [81]. Peripheral blood mononuclear cells responded to surplus dietary ARG 
with increased expression of CAT-1 [73]. 
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Table 1. Description of y
+
 system transporters 
Gene Tissue 
Distribution in 
mammals 
Tissue 
Distribution in 
chickens 
Approximate 
ARG Km in 
mammals 
Approximate 
ARG Km in 
chickens 
Sequence 
Homology
2
 
CAT-1 Ubiquitous, 
excluding liver 
Liver, skeletal 
muscle and 
bursa 
100-150 uM Unknown 94-96% 
CAT-2A Throughout 
the body, 
highest in liver 
Ubiquitous 2-5 mM 6.5 mM 78-81% 
CAT-2B Immune cells Bursa, heart, 
liver and 
thymus 
70-400 uM NF 83-85% 
CAT-2C n/a Ubiquitous n/a NF n/a 
CAT-3 Brain and 
placenta 
Pectoralis, 
bursa, heart, 
spleen and 
thymus 
40-165 uM Unknown 79-83% 
CAT-4 Placenta Unknown Unknown Unknown n/a 
1
Abbreviations: ARG, L-arginine; n/a, not applicable; NF, non-functions 
2
Sequence homology range compared to human, mouse and rat nucleotide sequences with BLAST 
(http://blast.ncbi.nlm.nih.gov/) 
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1.3.2 Systems y
+
L and b
0,+
 
The systems y
+
L and b
0,+
  include the unglycosylated transmembrane proteins y
+
LAT1/2 
and b
0,+
AT. These transporters form obligate heterodimers with the glycoproteins 4F2hc or 
rBAT [82, 95]. While y+LAT1/2 primarily associates with 4F2hc and b0,+AT with rBAT, 
overexpression of either 4F2hc or rBAT can produce different pairings [95]. Both transport 
systems are high affinity obligate exchangers that exchange neutral amino acids for cationic 
amino acids,  [82, 95]. Both y+LAT-1 and b
0,+
 are most abundantly expressed in the small 
intestine and kidney and indicate a role in amino acid absorption or reabsorption [19, 82, 95]. 
The transporter y
+
LAT-2, much like CAT-1, is ubiquitously expressed in mammalian tissues [19, 
82, 95].  
1.3.3 System B
0,+
 
 System B
0,+
 includes the Na
+
 and Cl
-
 dependent transporter ATB
0,+
, a high affinity 
glycosylated transmembrane transporter [19]. In addition to transporting CAAs ATB
0,+ 
is capable 
of transporting neutral amino acids with an apparent Km of 0.10-0.15 mM [19]. ATB
0,+
 is also 
the only Na
+
 dependent ARG transporter. In part due to its broad transport capacity, ATB
0,+
 has 
been a target for transmembrane drug delivery [96]. It has been shown in a wide variety of 
tissues including the mammary gland, pituitary gland, stomach, colon, and eye, but is most 
abundant in lungs and salivary glands [17, 19, 96]. 
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CHAPTER 2 
Nitric oxide synthesis by chicken macrophages results in coordinated changes of multiple 
arginine transporters 
Introduction 
Macrophages are vital to pathogen clearance, tumor suppression and wound healing [1-
3]. They act through phagocytosis, cytokine production, production of toxic molecules and 
antigen presentation cells [2-4]. They exist as quiescent monocytes in peripheral blood until 
induced to extravasate and mature into macrophages [5]. Macrophages derived from peripheral 
blood monocytes exhibit phagocytic behavior, cytokine production, nitric oxide production and 
major histocompatibility II expression [6, 7]. Macrophage activation can occur through localized 
tissue damage, stimulation of pattern recognition receptors (PRRs) or chemokine signaling [2, 8]. 
Commonly, lipopolysaccharide (LPS) or IFN-γ is used to simulate pathogen recognition in 
macrophages by stimulating either Toll-like receptor 4 (TLR-4) or the IFN-γ receptor [1, 3, 8, 9].   
Once activated, macrophages produce bacterially toxic compounds including nitric oxide 
(NO), the superoxide anion (O2
-
), hydrogen peroxide (H2O2), the hydroxyl radical (OH
-
) and 
hypochlorite (OCl
-
) [3, 10]. These compounds are produced inside endocytic vacuoles and 
destroy engulfed bacteria using enzymes such as inducible nitric oxide synthase (iNOS or 
NOS2), NADPH oxidase, superoxide dismutase and other peroxidase enzymes [10, 11]. This 
process is known as respiratory, or oxidative, burst due to the increase in oxygen consumption to 
produce microbicidal compounds. While NO production also requires oxygen, it is highly 
dependent on the presence of the catabolic substrate L-arginine (ARG) [9]. ARG is first oxidized 
to N-hydroxy-L-arginine, then to L-citrulline (CIT) and NO [12, 13]. The other metabolic fate of 
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ARG is catabolism by arginase to L-ornithine and urea [12, 14]. This reduces the ARG available 
for NO synthesis and can be utilized by bacterial species (e.g. Salmonella) to avoid destruction 
[14, 15]. 
Ureotelic animals, such as mammals, can recycle CIT or L-ornithine in the kidney to 
produce ARG and it is thus considered a conditionally essential amino acid [12]. While ARG 
synthesis from CIT has been shown in mouse macrophages, rat alveolar macrophages and 
chicken macrophages are unable to produce significant quantities of NO in low ARG, high CIT 
media [16-18]. Thus the capacity for ARG synthesis is not biologically relevant for NO 
production despite the presence of the requisite enzymes.  Uricotelic animals lack carbamoyl 
phosphate synthase I and ornithine transcarbamoylase and cannot synthesize the metabolic 
precursors of ARG [19].  Thus in aves, ARG is an essential cationic amino acid because it cannot 
be synthesized de novo. Avian macrophages are thus limited to ARG acquired in the diet for NO 
synthesis [9]. 
In mammals, ARG is imported into the macrophage by the cationic amino acid 
transporter 2B (CAT-2B) [20]. CAT-2B and iNOS mRNA transcription are co-induced in 
response to cytokine activation or TLR-ligand binding [20, 21]. Mouse macrophages lacking 
CAT-2B import 95% less ARG and produce 92% less NO [20]. The chicken CAT-2 gene is 
alternatively spliced to produce three isoforms (CAT-2A, CAT-2B and CAT-2C). Chicken CAT-
2A isoform is a high velocity, low affinity transporter that is predominantly expressed in the liver 
and skeletal muscle [22, 23]. Chicken CAT-2B is the isoform homologous to mammalian CAT-
2B; however, chicken CAT-2B does not transport LYS or ARG [22]. This difference has been 
attributed to a substitution of Lys
369
 for Glu
369
 in the affinity-conferring region of the transporter. 
The chicken CAT-2C isoform results in a non-functional, truncated protein [22]. 
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The other ARG capable transporters present in mammals and aves are CAT-1 and CAT-
3., CAT-1 and CAT-3 are high affinity transporters and have variable tissue distributions 
depending on species [23]. Chicken CAT-1 mRNA is found in the bursa, thymus, skeletal 
muscle and liver, but not in the heart or spleen [24]. In mammals, CAT-1 is found in nearly all 
tissues except hepatocytes [25]. Chicken CAT-3 has a slightly lower affinity than CAT-1 and is 
found in the bursa, thymus, heart and pectoralis [24]. The mammalian CAT-3 is expressed in the 
thymus, brain, uterus and testis [25]. With CAT-2B not importing ARG for chicken macrophage 
NO production, another transporter(s) must allow for ARG import. These broad differences in 
species CAT expression do not indicate a likely candidate for ARG import for NO production in 
aves. 
Due to the absence of a functional homologue to mammalian CAT-2B in the chicken 
macrophage, CAT-1, CAT-2A and CAT-3 were investigated for their role in ARG transport. 
Experiments were performed to: 1) identify the changes in ARG transporter mRNA abundance 
due to activation in primary and immortalized macrophages; 2) determine the effect of 
transiently over-expressing ARG transporters on NO production. 
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Materials and Methods 
2.1 Cell Culture 
HD11 cells obtained courtesy of Dr. Mike Kogut (Southern Plains Agricultural Research 
Center, TX) were cultured in T75 flasks (Corning, Corning, NY; 430720) in complete medium 
(IMDM without phenol red [Invitrogen, Carlsbad, CA; 12440], 5% fetal bovine serum 
[Invitrogen, Carlsbad, CA; 16000], 2% penicillin/streptomycin [Invitrogen, Carlsbad, CA; 
15140] and 1% L-glutamine [Sigma, St. Louis, MO; G7513]) at 37 C with 5% CO2.  
 
2.2 Experimental Design  
2.2.1 Experiment 1: Determining Experimental Conditions 
 HD11 cells for nitric oxide analysis were cultured in 96-well plates (Fisher, Pittsburg, 
PA; 353070) at 2x10
5
 cells/well (n=4/time point) in 200 µL complete media containing 0, 0.1, 1 
or 10 µg/mL Escherichia coli lipopolysaccharide (LPS; Sigma-Aldrich, St. Louis, MO; L4005). 
Media was collected at 24, 48 and 72 h for nitric oxide analysis.  HD11 cells for multiple time 
point nitric oxide analysis were cultured in 96-well plates at 4x10
5
 cells/well (n=3) in 300 µL of 
complete media containing 0 or 1 µg/mL LPS. Media (50 µL) was collected from either the same 
or different set of wells at 6, 18, 24, 36 and 48 h. Nitric oxide concentration from repeatedly 
sampled wells was corrected for the effect of reducing well volume with the following equation:  
yi =     
   –    
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where yi = corrected nitrite concentration of sample i; xi = raw nitrite concentration of sample i; 
xi-1 = x0 = 0 µM nitrite; Vi0 = Initial volume in µL; n = media volume sampled per time point in 
µL [26]. 
 
2.2.2 Experiment 2: Transporter Identification during a NO Response 
HD11 cells were cultured in 6-well plates (Fisher, Pittsburg, PA; 353046) at 4x10
5
 
cells/well (n=6) in complete media containing 0 or 1 µg/mL LPS. Media (500 µl) was collected 
at 24 and 48 h for nitric oxide analysis and cells were detached using cell scrapers (Fisher, 
Pittsburg, PA; 353085). Cells were centrifuged for 5 min at 500 x g at 25°C. The media was 
aspirated and cell pellets were flash frozen in liquid nitrogen and stored at -80°C. 
Peripheral blood was collected from Cobb 500 broilers (n=8) and Hyline W36 layers 
(n=7) by cardiac puncture into heparinized tubes for isolation of macrophages. Cells were 
analyzed for viability and the macrophage marker KUL01 by flow cytometry. Macrophages were 
plated in 6-well plates at 4x10
5
 cells/well in complete media containing 0 or 1 µg/mL LPS. 
Media (500 µl) was collected at 24, 48 and 72 h for nitric oxide analysis. Macrophages were 
collected at 72 h in RPMI-1640 (Invitrogen, Carlsbad, CA; 11879-020) using cell scrapers and 
were centrifuged for 5 min at 500 x g at 25°C. The media was aspirated and cell pellets were 
flash frozen in liquid nitrogen and stored at -80°C. 
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2.2.3 Experiment 3: Over-expression of CATs by Transient Transfection 
Transfected HD11 cells were plated in 96-well plates at 4x10
5
 cells/well in 300 µL 
IMDM complete media containing 0 or 1 µg/mL LPS. Supernatant (50 µL) was collected at 6, 
12, 24, 36 and 48 h. The remaining media was aspirated and the cells were detached with typsin 
(8.0g Sodium chloride [Fisher, Pittsburg, PA; S671], 0.4g potassium chloride [Fisher, Pittsburg, 
PA;  P217], 1.0g glucose [Sigma-Aldrich, St. Louis, MO; G8270], 0.35g sodium bicarbonate 
[Fisher, Pittsburg, PA;  S233], 0.5g Trypsin [Sigma-Aldrich, St. Louis, MO; T-4799], 0.2g 
EDTA [Sigma-Aldrich, St. Louis, MO; E8145], 0.06g potassium phosphate monobasic [Fisher, 
Pittsburg, PA;  P285], 0.09g sodium phosphate dibasic [Fisher, Pittsburg, PA;  S381] in 1L 
ddH20] for 10 min at 37°C with 5% CO2 and were quenched with complete media. Cells were 
analyzed by flow cytometry for viability and transfection efficiency. 
 
2.3 Macrophage isolation 
In experiment 2, macrophages were isolated from male 32d old Cobb 500 broilers (n=8) 
or actively laying Hyline W36 (n=7). Broilers and layers were provided access to water and a 
standard commercial ration ad libitum. Whole blood was collected into heparinized (Hospirin, 
Inc., Lake Forrest IL; 0409-1402-31) syringes via cardiac puncture and stored on ice. 
Heparinized blood was overlaid onto isovolumetric Histopaque-1077 (Sigma-Aldrich, St. Louis, 
MO; #10771) and centrifuged for 15 min at 350 x g at 25°C to obtain peripheral blood 
mononuclear cells. The buffy coat was reconstituted in RPMI-1640 (Invitrogen, Carlsbad, CA; 
22400) and centrifuged for 5 min at 500 x g at 25°C. Cell pellets were resuspended in RPMI-
1640 complete media (RPMI-1640 containing 5% fetal bovine serum, 2% 
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penicillin/streptomycin and 1% l-glutamine). The cells were then plated (cells from 1 bird/plate) 
in 10 cm
2
 plates (Fisher, Pittsburg, PA; 353003) overnight at 37 C with 5% CO2. After an 
overnight adherence, media was aspirated and the plates were washed twice with RPMI-1640 to 
remove heterophils and erythrocytes. The cells were then collected in RPMI-1640 complete 
media using cell scrapers and enumerated via hemocytometer. 
 
2.4 Nitric oxide assay 
Nitric oxide (NO) was measured in media samples collected from experiments 1-3 using 
the Griess Reagent System (Promega, Madison, WI; G2930) for optical density at 550 nm. 
Standard curves were run in triplicate to produce the predictive equation (R
2
 >0.99) used to 
calculate sample concentrations. Sample concentrations containing less than 2.5 µM nitrite were 
considered to be below the detection limit of the assay. 
 
2.5 Total RNA Isolation 
Total RNA was isolated from cell pellets collected in experiment 2 using NucleoSpin 
Extract II kits (Macherey-Nagel, Bethlehem, PA; 740955) per the manufacturers protocol. Total 
RNA was quantified at optical density 260 nm and 1 µg total RNA per sample was reverse 
transcribed using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA; 170-8891) according 
to the manufacturers’ protocol. 
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2.6 Quantitative Real-Time PCR 
Quantitative real-time PCR was performed on a 7500 Fast Real-Time PCR System 
(Applied Biosystems, Foster City, CA) using Fast SYBR Green Master Mix (Applied 
Biosystems, Foster City, CA; 4385610), 1 μL of reverse transcription cDNA product, and 10 
μmol/L of each primer (Table 1). Thermal cycling parameters were 1 cycle of enzyme activation 
at 95°C for 20 s and 40 cycles of denaturing at 95°C for 3 s and annealing and extending at 60°C 
for 30 s. After 40 cycles, melting curve analysis was performed at 95°C for 15 s, 60°C for 60 s, 
followed by a linear temperature increase of 0.5°C/s to 95°C while continuously monitoring 
fluorescence. Samples containing primer dimers were considered below the level of detection 
and were excluded from analysis. Relative mRNA abundance was calculated using the modified 
Δ-Δ equation as previously described [27]. Amplification efficiency was determined with 
LinRegPCR during the log-linear phase of amplification [28]. Normalization of target mRNA 
genes was performed by geometric averaging of non-normalized β-2 microglobulin, 
glyceraldehyde 3-phosphate dehydrogenase and hypoxanthine-guanine 
phosphoribosyltransferase using GeNorm software [29]. Data are represented as normalized fold 
abundance relative to 0 µg/mL LPS for each transporter. Since CAT-1 and HD11 CAT-3 mRNA 
was below the limit of detection in the 0 µg/mL LPS treatment data were normalized to y
+
LAT1. 
 
2.7 Transient Transfection 
HD11 cells were transiently transfected with expression vectors containing chicken CAT-
1, CAT-2A and/or CAT-3 using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA; 11668-
019).  The open reading frame (ORF) for chicken CAT-1, CAT-2A and CAT-3 were amplified 
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using Platinum Taq DNA polymerase and were cloned in-frame into pcDNA5/FRT/V5-HIS-
TOPO mammalian expression vector (Invitrogen, Carlsbad, CA). The forward primer contained 
a kozak sequence and the stop codon on the reverse primer was deleted to allow for expression 
of a C-terminal V5 epitope.  A control plasmid provided with the kit contained chloramphenicol 
acetyltransferase in the pcDNA5/FRT/V5-HIS-TOPO vector was used as an over-expression 
control. Lipofectamine (0.2 µg/well) was diluted in Opti-Mem (Invitrogen, Carlsbad, CA; 
31985) and allowed to conjugate with 0.2 µg plasmid/well in Opti-Mem for 20 min at 25°C. 
Conjugated plasmids were then added to IMDM incomplete media (no pen/strep) containing 
4x10
5
 cells/well and incubated for 4 h at 37C with 5% CO2. 
 
2.8 Flow Cytometry 
Primary macrophage and transfected cell viability were analyzed using the EasyCyte Plus 
System (Millipore, Danvers, MA) with a 488 nm argon laser with ViaCount Reagent (Millipore, 
Danvers, MA; 4000) per the manufacturer’s instructions. Primary cell isolates were analyzed 
using mouse monoclonal R-phycoerythrin (R-PE) conjugated antibody (Southern Biotech, 
Birmingham, AL; 8420-09) KUL01 specific for monocytes and macrophages. Transfection 
efficiency was analyzed using mouse monoclonal fluorescein isothiocyanate (FITC)-conjugated 
antibody (Invitrogen Carlsbad, CA; R963-25) specific for the V5 epitope. Cells were washed 
with DPBS (Invitrogen, Carlsbad, CA; 14040) and permeabilized with 0.2% Triton X-100 
(Integra Chemical Company, Kent, WA; T756.30.30) for 10 min. Cells were washed twice with 
DPBS and blocked with SuperBlock Blocking Buffer (Fisher, Pittsburg, PA; 37515) for 20 min. 
Excess blocker was removed with two DPBS rinses. Blocked samples were stained with 0.238 
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µg/mL anti-V5-FITC in DPBS for 1 h at 25°C protected from light. Cells were washed once with 
DPBS, detached by trypsin addition for 5 min at 37, and quenched with complete media without 
phenol red. Cells were then analyzed for FITC or R-PE fluorescence using Guava CytoSoft 
Software (Millipore, Danvers, MA) on EasyCyte Plus System.  
 
2.9 Statistics 
Dependent variables were analyzed by the general linear model (MiniTab Software, 
Minitab Inc. State College, PA) using either a one-way or two-way analysis of variance 
(ANOVA). The effect of LPS treatment on HD11 NO production, NO dose response and ARG 
transporter mRNA abundance were analyzed with a one-way ANOVA. Transfected HD11 NO 
and monocyte NO assays were analyzed by two-way ANOVA to determine the main effect of 
LPS treatment, sample origin, and their interaction. Differences were considered significant 
when P<0.05, and means were compared by student’s pair-wise comparison. Transfection 
efficiency and viability data were arcsin transformed to meet the conditions for ANOVA. Data 
are shown as untransformed means and pooled standard error. 
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Table 2. Primers for quantitative real-time PCR
a
 
a
Abbreviations: B2M = β -2 microglobulin; CAT = cationic amino acid transporter; GAPDH = glyceraldehyde 3-phosphate 
dehydrogenase; HPRT-1 = hypoxanthine phosphoribosyltransferase-1; NOS2 = nitric oxide synthase 2 or inducible nitric oxide 
synthase; y
+
L type amino acid transporter; 
Gene  Primer Sequence Amplicon Length (bp) Accession Number 
CAT1 Sense 5’-ACCTCCATCGTCATCTCCTTC-3’ 252 EU360441 
 Antisense 5’-AAGTCTTCAATGTGCCACCTATG-3’   
CAT2A Sense 5′-TGCTTTGTCTACAAGTCTTCTCG-3’ 165 EU360448 
 Antisense 5’-AATGCCATAATACCAGAGATGACC-3’   
CAT2B Sense 5’-CTTTGCTTGTCTGCTTCATGG-3’ 272 EU360449 
 Antisense 5’-CTTCGTTTTGGAATTGATTTGAGC-3’   
CAT3 Sense 5′-CCACGGGCACCAAACAGAAG-3′ 150 XM_420204 
 Antisense 5′-CAGTCAGCACCACGCAGATG-3′   
y+LAT1 Sense 5′-GTTGGAGCCAGAGAAGGACATC-3′  165 XM_418326 
 Antisense 5′-AAGCCAGTAGTTGAAGCAGTAGTAG-3′   
y+LAT2
 
 Sense 5′-TTGTTCTCTTATTCTGGTTGGGATAC-3′ 100 XM_001231336 
 Antisense 5′-TTGGCATAGACACAGCAATAGC-3′   
NOS2 Sense 5’-GCTGTACTCTTTGCGTCATTACTC-3’ 90 NM_204961.1 
 Antisense 5’-TGATTTCCCAGTCTCGGTTGC-3’   
GAPDH Sense 5’-GGTGCTGAGTATGTTGTGGAGTC-3’ 290 NM_204305.1 
 Antisense 5’-GTCTTCTGTGTGGCTGTGATGG-3’   
HPRT-1 Sense 5′-GCCAGACTTTGTTGGATTTGAAG-3′ 213 NM_204848 
 Antisense 5′-AGAGTTGAAGCCTGTGAGAGATAG-3′   
B2M Sense 5′-TGGAGCACGAGACCCTGAAG-3′ 161 XM_424099.2 
 Antisense 5′-TTTGCCGTCATACCCAGAAGTG-3′   
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Results 
2.10 Experiment 1: Determining Experimental Conditions 
 2.10.1 Timeline and Dose Response 
 In order to evaluate the conditions for a maximal NO response in the HD11 cell line, a 
timeline and dose response was performed. Surprisingly, the HD11 response to LPS showed no 
significant time-dose interaction (P>0.05; data not shown) or effect of time (P>0.05; data not 
shown). Maximal nitric oxide (NO) production occurred with 1 µg/mL LPS (Figure 1; P<0.05). 
Subsequent experiments were performed with 1 µg/mL LPS. 
 2.10.2 Repeat Sampling Conditions 
 In order to determine if repeat sampling had a biological or merely volumetric effect on 
NO production, repeat sampling was compared to single sampling and transformed repeat 
sampling. The HD11s produced no detectable NO by 6 h, regardless of LPS treatment (data not 
shown). At 18, 24 and 36 h there was no difference between NO concentrations between single-
sampled, repeat-sampled wells and corrected repeat-sampled wells (Figure 2A-C; P>0.05). By 48 
h, the repeat-sampled wells resulted in higher NO concentration compared to controls (Figure 
2D; P<0.05), but corrected repeatedly-sampled and controls produced the same amount of NO 
(P>0.05). As such repeat sampling had volumetric and not biological effects and subsequent 
experiments utilizing repeat sampling were adjusted using the concentration correction formula. 
  
42 
 
0
20
40
60
80
100
0 g/mL LPS
0.1 g/mL LPS
1 g/mL LPS
10 g/mL LPS
a
a
b
c
N
it
ri
c
 O
x
id
e
 (

M
)
  
Figure 2.  Nitric oxide production by HD11 cells (2x10
5
 cells/well). Means not sharing a 
common superscript (a-c) differ within a time point (P<0.05). Means did not differ between time 
points (P>0.05). Values represent the mean  SEM (n=12). 
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Figure 3. Nitric oxide production at 18h (A), 24h (B), 36h (C), and 48h (D) by HD11 cells 
(4x10
5
 cells/well) in response to LPS with or without repeated sampling and adjustment 
algorithms. Means not sharing a common superscript differ (P<0.05).  Values represent the mean 
 SEM (n=4). 
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2.11 Experiment 2: Transporter Identification during a NO Response 
 2.11.1 Nitric oxide response 
 Before quantifying the transporters involved in a NO response, the NO response was first 
verified by quantifying NO and iNOS mRNA.  In the HD11 cell line at 24 and 48 h (Figure 3A-
B), 1 µg/mL LPS increased NO concentrations above controls (P<0.05) and at 48 h LPS 
increased iNOS mRNA abundance 8.5-fold (P<0.05) above controls (Table 2). 
 After verifying a NO response in the HD11 cell line, the NO response to LPS in primary 
macrophages (Table 3) was evaluated by measuring NO and iNOS mRNA. The magnitude of 
NO production in response to LPS differed between layer and broiler macrophages (Figure 4).  
NO production by layer macrophages was greater than broiler macrophages at 24, 48 and 72 h 
post-LPS (Figure 4A-C). The broiler macrophage NO response to LPS was similarly increased 
over controls at all time points (P<0.05). In broiler and layer macrophages (Table 2), iNOS 
mRNA abundance increased (P<0.05) 3.22-fold and 2.79-fold, respectively. 
 2.11.2 Transporter mRNA Abundance 
 Once a NO response to LPS had been shown in cell line and primary macrophages, ARG 
capable transporters were quantified in all three cell types. Both CAT-1 and CAT-3 were 
induced in HD11s in the presence of LPS (Table 2). The low-affinity importer CAT-2A 
increased 1.68-fold (P<0.05) in response to LPS and CAT-2B mRNA was not detected in 
treatments or controls. In the presence of LPS, y
+
LAT-1 decreased 69.5% (P<0.05) and y
+
LAT-2 
mRNA abundance was unaltered (P=0.95). 
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 Broiler and layer macrophage CAT-1 mRNA was induced in response to LPS (Table 2). 
The mRNA abundance of CAT-2A and CAT-3 showed a similar pattern of change in both 
strains in response to LPS. CAT-2A mRNA increased 1.33-fold in broilers (P<0.05) and 1.28-
fold in layers (P<0.05) while CAT-3 mRNA increased 1.27-fold in broilers and 1.23-fold in 
layers (P<0.05). y
+
LAT-1 did not change in either strain in response to LPS (P>0.05), but 
y
+
LAT-2 increased (P<0.05) 2.35-fold in broilers and 2.24-fold in layers. 
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Figure 4. HD11 (4x10
5
 cells) nitric oxide production at 24 and 48 h. Asterisks represent 
significant difference (P<0.05) within a time point. Values represent the mean  SEM (n=6). 
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Figure 5. Nitric oxide production by macrophages from 32d old all male Cobb broiler chickens (A; n=8; 4x10
5
 cells/well) and 
actively laying White Leghorns (B; n=7; 4x10
5
 cells/well). Means not sharing a common superscript (a-d) differ (P<0.05). ND 
represents samples that were below the level of detection (<0.78 mM nitrite). Values represent the mean  SEM. 
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Table 3. Relative mRNA abundance of arginine transporters and inducible nitric oxide synthase in 
HD11 and primary macrophages from broilers and layers
1 
1
values represent fold mRNA abundance relative to 0µg/mL LPS; NA = not applicable; ND = not 
detected; CAT = cationic amino acid transporter; y
+
L type amino acid transporter;
 
iNOS2 = nitric oxide 
synthase 2 or inducible nitric oxide synthase. 
2
Indicates mRNA detected in 1µg/mL LPS and no detectable mRNA in 0 µg/mL LPS. 
  
 
 
Gene 
 
 
Cell Source 
 
Relative mRNA 
Abundance 
 
 
P-value 
CAT-1 HD11 Induced
2
 NA 
 Broiler  Induced
2
 NA 
 Layer  Induced
2
 NA 
CAT-2A HD11 1.676±0.241 <0.05 
 Broiler  1.327±0.058 <0.05 
 Layer  1.283±0.129 <0.05 
CAT-3 HD11 Induced
2
 NA 
 Broiler  1.265±0.063 <0.05 
 Layer  1.227±0.085 <0.05 
y
+
LAT-1 HD11 .3049± 0.186 <0.05 
 Broiler  1.052±0.164 0.387 
 Layer  1.023±0.304 0.856 
y
+
LAT-2
 
 HD11 1.034± 0.812 0.950 
 Broiler  2.352±0.115 <0.05 
 Layer  2.242±0.267 <0.05 
iNOS HD11 8.514± 0.159 <0.05 
 Broiler  3.216±0.247 <0.05 
 Layer  2.794±0.168 <0.05 
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Table 4. Primary cell isolate viability and KUL01 staining for verification of macrophage 
phenotype from broilers and layers identified by flow cytometry
1 
1
Means not sharing a common superscript differ (P<0.05). Values represent the mean±SEM (n=3) 
2
Viable cells per 1000 events 
3
KUL01 positive cells per 5000 events 
  
 
Cell Source 
 
Viable Cells
2
 
 
KUL01 Positive Cells
3
 
 
Cell Count 
Broiler 934±32.8. 3052±118 1.49±0.13x10
6a
 
Layer 910±26.5 2572±135 2.43±0.16x10
6b
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2.12 Experiment 3: Over-expression of CATs by Transient Transfection 
 2.12.1 High Affinity Transporter Transient Transfection 
 The initial transient transfection was performed using the two high affinity ARG 
importers that were found to be induced or increased in response to LPS, CAT-1 and CAT-3. 
Transient transfection was performed with CAT-1, CAT-3 or CAT-1/CAT-3 plasmids and 
utilizing a non-plasmid mock transfection as a control. At 6 h post LPS treatment, no effect of 
LPS treatment was seen (P>0.05), but all transfected cells showed an increase of 15-18 µM NO 
compared to mock transfected controls (Figure 5A; P<0.05). After 12 h, mock transfected 
controls produced NO in response to LPS at a lower concentration than all plasmid treatments 
(P<0.05; Figure 5B). LPS increased NO production in CAT-1 transfected cells above transfected 
cells treated with 0 µg/mL LPS and multiple plasmid transfected cells treated with LPS (P<0.05). 
By 24 h, the CAT-1 with 1 µg/mL LPS combination produced the highest concentration of NO 
(P<0.05) followed by mock transfected cells with 1µg/mL LPS. The mock transfection with LPS 
produced more NO than non-LPS treated transiently transfected cells (P<0.05; Figure 5C). After 
36 h, over-expressing CAT-1 in the presence of LPS produced the maximal response of 89.3 µM 
NO (P<0.05; Figure 5D). In the absence of LPS, CAT-1 transfected cells produced the same 
amount of NO as the transfection control treated with LPS at 48 h (P>0.05). Cells transfected 
with CAT-3 produced the same amount of NO, independent of LPS or CAT-1 co-over-
expression, and at a lower concentration than LPS positive controls. 
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Figure 6. Nitric oxide production at 6h (A), 12h (B), 24h (C), and 36h (D) by HD11 cells (4x10
5
 
cells/well) transfected with no plasmid, CAT-1 plasmid, CAT-3 plasmid and CAT-1/CAT-3 
plasmids. Means not sharing a common superscript (a-d) differ (P<0.05). Values represent the 
mean  SEM (n=8). 
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 2.12.2 Evaluation of Controls for Transient Transfection 
 After observing the inhibitory response of CAT-3 plasmid in response to LPS compared 
to mock transfected cells, further transfections were performed to evaluate mock transfection as a 
control. A second transfection was performed using the mock transfection as one control and a 
transient transfection with plasmid containing a non-transporter gene (chloramphenicol-
acetyltransferase) as a plasmid control. CAT-3 transfection was repeated here as a sample 
experimental treatment shown to exhibit sub-maximal NO production. 
 After 6 h, no effect of LPS was observed (P<0.05), but all plasmid transfected cells 
showed the same increased NO response over the non-plasmid controls (P<0.05; Figure 6A). The 
non-plasmid control and CAT-3 treatment showed similar NO production in response to LPS at 
12 hours (Figure 8B). The control plasmid transfected cells and non-LPS treated transfected cells 
all produced similar amounts of NO (P>0.05). At 24 h, the non-plasmid control produced the 
highest concentration of NO at 93.2 µM in response to LPS (P<0.05; Figure 6C). The cells over-
expressing CAT-3 in the presence of LPS produced more NO (P<0.05) than the plasmid control 
cells with LPS or non-LPS treated plasmid transfected cells, which all produced similar 
quantities of NO (P>0.05). At 36 and 48 h, the non-plasmid transfected cells in the presence of 
LPS produced the highest NO concentration (P<0.05) with over-expressed CAT-3 cells 
producing the 2
nd
 highest concentration in response to LPS (P<0.05; Figure 6D-E). From 36 h 
onward CAT-3 transfected cells not treated with LPS produced more NO than the plasmid 
control (P<0.05), which produced the same quantity of NO regardless of LPS treatment 
(P>0.05).  
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Figure 7. Nitric oxide production at 6h (A), 12h (B), 24h (C), 36h (D) and 48h (E) by HD11 
cells (n=8; 4x10
5
 cells/well) transfected with no plasmid, control plasmid and CAT-3 plasmid. 
Means not sharing a common superscript (a-e) differ (P<0.05). Values represent the mean  
SEM (n=8). 
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 2.12.3 Transient Transfection 
 In order to evaluate effect of over-expression of the CATs and to account for the effect of 
plasmid-LPS interaction, another transfection was performed. The transfection was performed 
using both mock transfected and plasmid controls alongside CAT-1, CAT-2A, CAT-3 and CAT-
1/2A/3. After 6 h, no effect of LPS was observed (P>0.05), but CAT-1 and CAT-1/2A/3 plasmid 
treatments produced higher concentrations of NO than other transiently transfected cells (Figure 
7A). Over-expressing CAT-3 only resulted in moderate amounts of NO production while CAT-
2A alone produced the same amount of NO as the plasmid control at 6 h. At 12 h post LPS 
incubation NO production was observed in mock transfection controls with LPS at higher 
concentration than in either plasmid controls with LPS or CAT-2A over-expressed cells with 
LPS (P<0.05; Figure 7B). From 12 to 48 h post LPS treatment, over-expressed CAT-1 with LPS 
produced maximal NO (P<0.05; Figure 7B-E). Until 36 h post LPS treatment, the CAT-1/2A/3 
treated cells produced more NO in response to LPS than mock transfected controls, but no 
difference existed after 48 h (Figure 7E). In non-LPS treated cells, over-expression of CAT-1 
produced the highest concentration of NO with CAT-1/2A/3 producing slightly lower amounts 
between 24 and 48 h (P<0.05; Figure 7C-E). Mock transfected cells in the presence of LPS 
equaled NO production from CAT-1/2A/3 without LPS by 24 h (P>0.05; Figure 7C), equaled 
CAT-1 without LPS by 36 h (P>0.05; Figure 7D) and exceeded all non-LPS treated 
combinations by 48 h (P<0.05; Figure 7E). Both CAT-2A and the plasmid control induced low 
amounts of NO production in the absence of LPS at all time points, but in the presence of LPS 
small increases in NO production were observed (P<0.05). 
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Figure 8. Nitric oxide production at 6h (A), 12h (B), 24h (C), 36h (D) and 48h (E) by HD11 
cells (4x10
5
 cells/well) transfected with no plasmid, control plasmid, CAT-1, CAT-2A, CAT-3 
and CAT-1/CAT-2A/CAT-3 plasmids. Means not sharing a common superscript (a-j) differ 
(P<0.05). Values represent the mean  SEM (n=8). 
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 2.12.4 Transfection Verification 
 After transfecting with dual controls and the full spectrum of CATs, transfected cells 
were analyzed by flow cytometry to evaluate the potentially detrimental effect of lipofectamine 
transfection and LPS. Transfected HD11 cell viability did not differ due to plasmid contents or 
lack of plasmid (P=0.66) or LPS treatment (P=0.13), though a numerical decrease was observed 
in treatments with increased quantities of plasmid (Table 4). The total number of cells recovered 
did not differ by transfection treatment (P=0.81) or LPS (P=0.85). 
 The transfected cells were analyzed for successful transfection by V5-epitope staining. 
The number of the successfully transfected cells producing V5-tagged proteins did not differ by 
plasmid content (P>0.05) or LPS treatment (P=0.94) and mock transfection resulted in no 
evidence of V5-positive transfection product (P<0.05).
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Table 4. Recovered viable, v5-positive stained and original cells per well from transiently 
transfected HD11 cells identified by flow cytometry
1 
1
Means not sharing a common superscript differ (P<0.05), Values represent the mean±SEM (n=4) 
2
Viable cells per 1000 events 
3
v5 positive cells per 5000 events 
  
 
 
 
LPS 
 
Viable Cells
2
 
 
v5 Positive Cells
3
 
 
Cells/well 
Mock Transfected 
0 µg/mL 950±12.9 18±2.8
a
 3.34±0.15x10
5
 
1 µg/mL 969±6.9 26±4.6
a
 3.34±0.25x10
5
 
Plasmid Control 
0 µg/mL 959±6.9 1652±12.0
b
 3.36±0.78x10
5
 
1 µg/mL 929±12.5 1602±21.6
b
 3.23±0.16x10
5
 
CAT-1 
0 µg/mL 932±10.5 1607±18.1
b
 3.22±0.14x10
5
 
1 µg/mL 935±27.1 1612±46.7
b
 3.27±0.26x10
5
 
CAT-2A 
0 µg/mL 938±16.2 1616±27.9
b
 3.17±0.85x10
5
 
1 µg/mL 923±22.0 1591±38.0
b
 3.26±0.24x10
5
 
CAT-3 
0 µg/mL 927±9.0 1597±15.5
b
 3.190.11x10
5
 
1 µg/mL 905±15.3 1559±26.4
b
 3.16±0.13x10
5
 
CAT-1/2A/3 
0 µg/mL 890±15.7 1534±27.1
b
 3.03±0.18x10
5
 
1 µg/mL 898±21.3 1548±36.7
b
 3.17±0.23x10
5
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Discussion 
The transporters coordinating ARG uptake in the chicken macrophage for a NO mediated 
immune response have not been fully elucidated. Previous studies indicate that the avian 
mechanism differs from the mammalian system which relies on CAT-2B because the chicken 
CAT-2B protein does not transport ARG [20, 22]. These experiments provide evidence that in 
the absence of a CAT-2B based system, CAT-1 and CAT-3 both act in support of an oxidative 
burst in the chicken macrophage. 
In general chickens are relatively insensitive to LPS, a dose of 1 mg/kg may be required 
to induce an inflammatory response whereas in humans dosages as low as 2-4 pg/kg can induce 
an immune response [30]. In production animals, an immune response can be detrimental to 
weight gain, feed intake and protein accretion, increasing the cost of production [31]. As a result, 
chicken breeding in favor of production traits has led to animals which are relatively insensitive 
to LPS [30]. The short generation cycle and human-centered selected is in contrast to humans, 
where survival is the dominant pressure is survival. These differences in sensitivity and 
inflammatory response correlate with critical differences in ARG utilization by macrophages of 
uricotelic species, like chickens, and ureotelic species like mice and humans.  
The ARG capable importers show a similar pattern of increase and induction in the 
broiler and layer macrophage. These mRNA abundance similarities exist despite the confounding 
effects of age and sex of the birds. This pattern indicates a conserved mechanism for obtaining 
extracellular ARG for NO production. The high affinity ARG importer CAT-1 was induced in 
primary macrophages and the immortalized HD-11 macrophage cell line. A second high affinity 
ARG importer, CAT-3, was increased in primary macrophages and induced in cell line 
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macrophages. While CAT-2A also increased, it is a low affinity ARG transporter and in 
mammals is insufficient to increase constitutive NO production [22]. The absence of detectable 
CAT-2B in these experiments support earlier work showing CAT-2B- not being involved in NO 
production as it is in mammals [20, 22]. This makes the chicken macrophage a unique model 
rendering mammalian-based predictions on ARG utilization for NO production tenuous at best. 
CAT-1 and CAT-3 are capable of sustaining constitutive NO production when transiently 
induced in cultured macrophages. Over-expressing CAT-1, but not CAT-3, during a LPS-
induced respiratory burst produced maximal NO. However, CAT-3 has also been shown to 
restore NO production in CAT-1 deficient cells [32]. CAT-2A over-expression increased NO by 
34% in response to LPS at 48h, a marginal increase compared to CAT-1, a 1045% increase, or 
CAT-3, a 450% increase. These data indicate that CAT-1 is the dominant ARG importer for NO 
production in the chicken macrophage, but that CAT-3 is also sufficient for a NO response. The 
capacity of these transporters to facilitate a NO response without an immunogen indicates that 
the limiting factor in immortalized chicken macrophages is not iNOS but the availability of 
catalytic substrate ARG.  
 The y
+
LAT system of exporters showed an inverse relationship with the magnitude of 
NO produced in broiler and layer macrophages. Decreased levels of y
+
LAT-1 in the HD11 
macrophage in response to LPS were observed in conditions that resulted in high levels of NO 
production (~100µM). The converse was observed in macrophages from both broiler and layer 
chickens where y
+
LAT-2 increased and maximal levels of NO were ~10-25% of the maximal 
production observed in HD11s. The increase in y
+
LAT2 may enable ARG export as shown in 
erythrocytes and fibroblasts but not in other tissues [33, 34]. This increase in y
+
LAT2 may be 
preparing the cell to down-regulate the NO response after pathogen clearance. Despite the 
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correlation between the y
+
LAT type exporter mRNA abundance and NO response, the effect of 
increased ARG importers by transient transfection indicates importers and not exporters are 
limiting for NO production. These magnitude differences concur with other studies showing that 
transformed cell line macrophages are more responsive to LPS than primary macrophages of 
varying genetic lineage [35]. 
 The relative change in iNOS mRNA abundance showed a positive relationship with the 
magnitude of the NO response. The enzyme iNOS is typically thought of as an inducible 
enzyme. The presence of iNOS mRNA without stimulation and the NO response at 6h when the 
cells were transfected with CAT containing plasmid indicates a constitutive presence of the 
enzyme. Utilizing siRNA in the HD11 cell line, iNOS mRNA abundance can be reduced as 
much as 50-fold, but the decrease in NO production ranges 14-28% at 48 h [36]. These data 
indicate post-transcriptional control, such as substrate availability, in the respiratory burst 
mechanism of chicken macrophages. The maximal NO concentrations observed were limited by 
intracellular ARG availability, ARG uptake, or iNOS abundance rather than ARG in the culture 
medium. ARG in the medium was present at a concentration approximately 4-fold more 
abundant than the amount utilized and double the 200µM threshold at which increased ARG 
increases NO production [16]. As such, the culture media ARG concentration was not a pertinent 
factor in observed NO response to LPS. 
 While genetic similarities between production animals exist despite the confounding 
factors of age and sex, the magnitude of their NO response was greater than 2-fold different by 
72h. The sensitivity of aging individuals and sex-related differences occur across species [37-
40]. Senescent mice show higher sensitivity to LPS and have increased NO production mediated 
by TNF-α [40]. Young mice are less sensitive than senescent animals, but more responsive to 
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LPS than mature mice [40]. While TNF-α was not investigated in this study, the LPS sensitivity 
and NO production trend would be similar if we compared young and senescent birds, but is 
inverted when comparing young and mature birds. Studies in humans show that females have a 
stronger pro-inflammatory response to LPS than males via increased IL-6 and IL-10 [39]. In 
female mice, macrophages produce as much as 50% more NO in response to an immune 
challenge [38]. Male-Female differences have been attributed to sex hormones, notably estradiol, 
differences in cytokine production and differences in acute phase proteins [37-39]. Female mice 
produce higher levels of pro-inflammatory cytokines TNF-α, IL-1β and IL-6 in response to LPS 
[37, 38]. Serum hormone levels, acute phase proteins and cytokine production were not 
investigated in these experiments but the trend shows an increased sensitivity to LPS and NO 
production in female chickens when compared with males. Thus the increases in NO production 
by older, female chickens are explicable and likely due to parameters beyond the scope of these 
experiments. 
 Increasing the abundance of all importers was sufficient for constitutive NO production, 
but did not to increase LPS-induced NO production. These data indicate that increasing the 
quantity of plasmid beyond 0.67 µg/mL does not increase the number of recoverable cells 
positive for V5 epitope tagged protein(s). The amount of V5 tagged protein was not quantified, 
thus it is possible that increased plasmid can increase protein production or increased plasmid 
splits the transfection result between the different plasmids. The C-terminus of the transporters 
containing the V5 epitope are intracellular, but extracellular domains may be degraded by the 
trypsin solution used to detach the cells from their culture environment [25]. These partially 
degraded proteins may not be accurately represented by α-V5 epitope antibody tagging. 
Transfecting with non-transporter containing plasmids resulted in minor amounts of NO 
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indicating that any plasmid, regardless of contents, may be recognized and induce a separate 
immune response through TLR9 [41]. A TLR9 mediated response would antagonize the TLR4 
response stimulated by LPS by interfering with the MAPKs and NF-κB signaling pathways [42].  
Transfection with foreign sources of DNA or RNA has been shown to silence host transcription 
and translation [43]. As such, the transient transfections may resemble sole expression of 
transporter in question and not over-expression, hence why transfection with the all three CATs 
results in an LPS induced response similar to mock transfection. 
 These experiments indicate that the respiratory burst mechanism in the chicken 
macrophage can be mediated by CAT-1 or CAT-3. A maximal NO response is mediated by over-
expressing CAT-1 and thus may provide a target for evaluating genetic differences in chicken 
strains. Selective breeding of chickens for divergent purposes to maximize production capacity 
has not altered the pattern of CAT changes between breeds observed in a NO response to LPS, 
but instead shows indications of altering the magnitude of the response. Gram-negative bacteria 
such as Salmonella pose significant financial risk to the poultry industry, especially in flocks of 
layers. If increases in CAT-1 or CAT-3 can be correlated with increased pathogen clearance by 
chicken macrophages, they could prove valuable targets for selective breeding. 
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CHAPTER 3 
Conclusions 
5.1 Summary 
CAT-1 and CAT-3 are both sufficient to provide for sustained NO production in the 
absence of an immunogen. CAT-1 is induced in response to a simulated bacterial infection and 
provides for a maximal NO response when over-expressed. These results indicate that respiratory 
burst mechanisms in aves are mediated by multiple import-export systems unlike mammals that 
depend on a single importer. 
5.2 Future Studies 
To further elucidate the role of each transporter in the complete NO response additional 
trials need to be conducted using knock-out cells or siRNA to inhibit the importers. Additionally, 
the biological significance of increasing or decreasing the magnitude of the respiratory burst 
should be evaluated. The phagocytic and bactericidal effect of differing levels of NO production 
would show the animal level value in eradicating infections from pathogens like Escherichia coli 
and Salmonella spp. While an increased response might increase pathogen clearance, to dramatic 
an increase in NO production can also cause oxidative damage to the host animal. 
To further explore the issue of male-female and age related confounding factors, the 
mRNA quantification should be replicated in small-scale age matched animals. Young sexed 
broilers are available and could be raised concordantly with replacement layers and roosters to 
suss out these interactions. 
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 Arginase II has been shown to regulate pathogenicity of Salmonella in mouse 
macrophages by altering the fate of ARG [1]. Efforts to identify and sequence either arginase I or 
II in the chicken macrophage have thus far been unsuccessful (data not shown). 
5.3 Implications 
These results show the potential to identify on a breed and/or gender basis the predicted 
animal sensitivity and responsiveness to gram-negative bacterial challenges. While increased 
innate immune activity may increase bird survival, it also negatively impacts performance. Thus 
the task of identifying optimal immune responsiveness may remain a distant goal. 
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APPENDIX 
Figure 9. Representative image of ViaCount of HD11 cells on EasyCytePlus Flow cytometer.
1
 
 
1
Abbreviations: FSC, forward scatter. 
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Figure 10. Representative image of KUL01-PE of peripheral blood mononuclear cells on 
EasyCytePlus Flow cytometer.
1,2
  
 
1
Grey indicates KUL01-PE stained cells; black indicates cells not stained with KUL01. 
2
Abbreviations: KUL01-PE, macrophage specific antibody conjugated to R-phycoerythrin. 
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Figure 11. Representative V5-FITC staining image of transiently transfected HD11 cells on 
EasyCytePlus Flow cytometer. 
1,2
  
1
Grey indicates V5-FITC stained cells; black indicates cells not stained with V5. 
2
Abbreviations: V5, transfect target epitope specific antibody conjugated to fluorescein. 
 
